Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback By: Benzinga via Benzinga July 09, 2014 at 12:37 PM EDT Shares of Celgene (NASDAQ: CELG) have been volatile since the company announcedweak Phase III trial resultsfor ... Read More >> Related Stocks: Celgene Corp